Alternative treatment regimens in autoimmune hepatitis: how justified is their choice?
Autoimmune hepatitis is a progressive immune-mediated liver disease of unknown etiology. Its key characteristics include hyper-gammaglobulinemia, circulating autoantibodies, and periportal inflammation seen in a liver biopsy sample. It is not infrequent that the lack of unified diagnostic tests make...
Main Authors: | M. V. Matsievich, A. O. Bueverov, M. Yu. Petrachenkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2018-11-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/887 |
Similar Items
-
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01) -
Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
by: Iqbal A, et al.
Published: (2000-01-01) -
The use of immunosuppression in autoimmune hepatitis: A current literature review
by: Angela Cropley, et al.
Published: (2017-03-01) -
Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01) -
Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)